Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
RGEN
RGEN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
RGEN News
Repligen Corporation to Report Q4 2025 Financial Results on February 24, 2026
6d ago
Newsfilter
RGEN Stock 52-Week Highs and Lows Analysis
Feb 06 2026
NASDAQ.COM
UBS Raises Repligen's Price Target to $200, Citing 20% Order Growth
Jan 23 2026
Yahoo Finance
Repligen Elects Martin Madaus as Board Chair Effective March 13
Jan 06 2026
NASDAQ.COM
Canaccord Genuity Keeps Hold Rating on Repligen and Increases Price Target to $165
Oct 29 2025
Benzinga
Repligen (RGEN) Exceeds Expectations in Q3 Earnings and Revenue
Oct 28 2025
NASDAQ.COM
Analysts Predict 10% Growth Potential for PTL
Oct 28 2025
NASDAQ.COM
Barclays Keeps Overweight Rating on Repligen and Increases Price Target to $160
Oct 02 2025
Benzinga
Insights from 8 Analyst Ratings on Repligen
Oct 01 2025
Benzinga
Deutsche Bank's Top 38 Stock Recommendations, Including Amazon and Palo Alto Networks
Oct 01 2025
MarketWatch
Key Analyst Recommendations for Wednesday: Nvidia, Apple, Tesla, Delta, Carvana, Coinbase, and Others
Oct 01 2025
CNBC
Sarepta Therapeutics Analyst Becomes Optimistic; Check Out the Top 5 Upgrades for Monday
Sep 22 2025
Benzinga
Evercore ISI Group Boosts Repligen Rating to Outperform and Increases Price Target to $155
Sep 22 2025
Benzinga
Jefferies Keeps Hold Rating on Repligen, Reduces Price Target to $135
Sep 12 2025
Benzinga
HC Wainwright & Co. Affirms Buy Rating for Repligen, Keeps $180 Price Target Intact
Sep 03 2025
Benzinga
Analysts Predict SCHX Will Hit $28
Aug 25 2025
NASDAQ.COM
Show More News
